PUBLISHER: The Business Research Company | PRODUCT CODE: 1825987
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825987
Cardiac ambulatory monitoring involves the continuous tracking and evaluation of a patient's heart activity while they engage in their everyday activities outside of a clinical environment. This monitoring is commonly used to identify arrhythmias, assess the effectiveness of cardiac treatments, and evaluate heart health over a prolonged period.
The primary types of cardiac ambulatory monitoring include electrocardiogram (ECG) devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. Electrocardiogram (ECG) devices are medical tools that record the heart's electrical activity, offering vital information for diagnosing cardiac issues. Within this field, there are both single-specialty and multi-specialty practices. The key users of these monitoring devices are hospitals, ambulatory surgical centers, specialty clinics, cardiac care centers, and home care environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The cardiac ambulatory monitoring market research report is one of a series of new reports from The Business Research Company that provides cardiac ambulatory monitoring market statistics, including the cardiac ambulatory monitoring industry's global market size, regional shares, competitors with a cardiac ambulatory monitoring market share, detailed cardiac ambulatory monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac ambulatory monitoring industry. This cardiac ambulatory monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cardiac ambulatory monitoring market size has grown strongly in recent years. It will grow from $14.17 billion in 2024 to $14.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness of heart health, growing adoption of wearable devices, rising aging population, and growing focus on outpatient care and remote monitoring.
The cardiac ambulatory monitoring market size is expected to see strong growth in the next few years. It will grow to $18.48 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising personalized healthcare approaches, increasing adoption of mobile health applications, improving telemedicine infrastructure, rising healthcare expenditure, and governmental support for preventive healthcare initiatives. Major trends in the forecast period include artificial intelligence (AI)-driven predictive analytics, integrating cloud solutions, the miniaturization of monitoring devices, incorporating real-time data analysis with wearables, and advancements in battery life for continuous monitoring.
The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. cardiology by increasing the cost of patch ECG monitors and mobile cardiac telemetry devices sourced from Israel and Germany, thereby delaying arrhythmia detection and elevating outpatient monitoring costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of cardiovascular disease is expected to drive the growth of the cardiac ambulatory monitoring market. Cardiovascular disease (CVD) encompasses various conditions that affect the heart and blood vessels, including heart attacks, strokes, and heart failure. These diseases typically result from blockages in blood vessels or irregularities in heart function. Contributing factors include poor diet, lack of exercise, smoking, stress, and an aging population. Additionally, conditions such as obesity, diabetes, and hypertension are amplifying the incidence of CVD. Cardiac ambulatory monitoring enables continuous tracking of heart activity, which helps detect irregularities early in patients with cardiovascular conditions. This approach allows for more effective management of heart issues by facilitating real-time diagnosis and monitoring, reducing the need for frequent hospital visits. For example, according to the British Heart Foundation in September 2024, approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. By 2030, the number of affected individuals could rise by 1 million, and by 2040, it could increase by an additional 2 million. As such, the growing prevalence of cardiovascular diseases is propelling the cardiac ambulatory monitoring market.
Companies in the cardiac ambulatory monitoring market are focusing on developing innovative technologies such as artificial intelligence (AI) and Bluetooth-enabled electrocardiogram devices to improve patient monitoring and data accuracy. These advanced tools use AI algorithms for real-time heart data analysis and Bluetooth technology to wirelessly transmit the information to healthcare providers. In September 2024, AliveCor Inc., a US-based company offering remote cardiac care, launched the KardiaMobile Card. This portable device allows users to monitor their heart health in real time, particularly for detecting arrhythmias and managing heart conditions directly from their wallet. The KardiaMobile Card makes heart health data easily accessible, promoting early detection of heart issues and helping to reduce the economic impact of cardiovascular diseases.
In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition is set to enhance WearLinq's nationwide clinical services and expand access to its FDA-cleared eWave 6-lead wearable ECG monitor. This move strengthens the company's position in the cardiac diagnostics market, establishing it as a key player. AMI Cardiac Monitoring LLC is an independent US-based diagnostic testing facility specializing in ambulatory cardiac monitoring.
Major players in the cardiac ambulatory monitoring market are Abbott Laboratories, Medtronic PLC, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Hill-Rom Holdings Inc., Nihon Kohden Corporation, MicroPort Scientific Corp., Fukuda Denshi Co. Ltd., iRhythm Technologies Inc., ZOLL Medical Corporation, Schiller AG, Biotronik SE & Co. KG, Medicomp Inc., Applied Cardiac Systems, Bardy Diagnostics Inc., ACS Diagnostics Inc., WebCardio LLC, ReactDx
North America was the largest region in the cardiac ambulatory monitoring market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cardiac ambulatory monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiac ambulatory monitoring market consists of revenues earned by entities by providing services such as holter monitoring, patch electrocardiogram monitoring, mobile cardiac telemetry (MCT), and wireless remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac ambulatory monitoring market also includes sales of remote patient monitoring systems, wearable fitness trackers, and cardiac rehabilitation monitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Ambulatory Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiac ambulatory monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac ambulatory monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac ambulatory monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.